Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome

Published:2022-06-05 Issue:8 Volume:4 Page:689-699
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheumatology

Author:

Pepple Sophanit¹,Arnold Jack¹,Vital Edward M.¹²,Rawstron Andrew C.³,Pease Colin T.¹,Dass Shouvik²,Emery Paul¹²^ORCID,Md Yusof Md Yuzaiful¹²^ORCID

Affiliation:

1. Leeds Institute of Rheumatic and Musculoskeletal Medicine University of Leeds Leeds UK

2. NIHR Leeds Biomedical Research Centre Leeds Teaching Hospitals NHS Trust Leeds UK

3. Haematological Malignancy Diagnostic Service Leeds Teaching Hospitals NHS Trust Leeds UK

Funder

Research Trainees Coordinating Centre

Wellcome Trust

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11466

Reference55 articles.

1. B cells in the pathogenesis of primary Sjögren syndrome

2. Primary Sjögren's syndrome and malignancy risk: a systematic review and meta-analysis

3. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren’s syndrome

4. The value of rituximab treatment in primary Sjögren's syndrome

5. Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab;Reactions Weekly;2023-07-08

2. Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases;Frontiers in Medicine;2022-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3